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Open access under CC BMicroRNAs (miRNAs) comprise a post-transcriptional layer of gene regulation shown to be involved in
diverse physiological processes. We aimed to study whether regulatory networks that determine suscep-
tibility to hypertension may involve a miRNA component. Screening of loci, involved in renal water–salt
balance regulation, highlighted the mineralocorticoid receptor gene NR3C2 as a potential target for sev-
eral miRNAs. A luciferase assay demonstrated that miR-124 and miR-135a suppress NR3C2 30UTR repor-
ter construct activity 1.5- and 2.2-fold, respectively. As the tested miRNAs did not reduce the levels of
target mRNA, we suggest that the binding of miR-124 and miR-135a to NR3C2 30UTR contributes to
the translational, not transcriptional regulation of the gene. Co-expression of two different miRNAs did
not increase the repression of the reporter gene, indicating no additive or synergistic effects between
the tested miRNAs.
Our results demonstrate that by repressing the mineralocorticoid receptor gene NR3C2, miR-124 and
miR-135a could participate in the regulation of renin–angiotensin–aldosterone system and thereby
might be involved in blood pressure regulation.
 2009 Elsevier Inc. Open access under CC BY license.Introduction and environmental factors [8,9]. A number of genetic studies haveMicroRNAs (miRNAs), small noncoding RNA molecules, are
endogenous post-transcriptional regulators that function as guide
molecules, pairing with partially or fully complementary motifs
in 30UTRs of their target mRNAs [1]. In animal cells, the prevalent
effect of miRNAs is translational repression of the target mRNA
without affecting the levels of mRNA itself, although the mecha-
nisms that induce target mRNA degradation by RNA induced
silencing complex mediated cleavage [2] or rapid deadenylation
[3] and decapping [4] have also been reported. Recently, transcrip-
tional and post-transcriptional levels of gene regulation have been
combined into the hypothesis that combinatorial control by tran-
scription factors and miRNAs may be involved in regulation of
the majority of cellular pathways [5,6]. Involvement of miRNAs
in fundamental biological processes raises the hypothesis that
alterations in miRNA-controlled pathways may cause developmen-
tal abnormalities and various human disorders. Indeed, it has been
shown that miRNAs can play an important role in etiology of can-
cer and other diseases [7]. Despite that, the functional role of most
of the miRNAs in human physiology is still poorly understood.
Essential hypertension is a complex disorder, caused by the
interplay between many genetic variants, gene–gene interactionsn@ut.ee (M. Laan), tannilo@
Y license.been conducted to unscramble the complicated blood pressure-
regulating genetic networks, resulting in a large number of candi-
date genes, sequence variants and quantitative trait loci, mostly
with modest effect [8,10,11]. The most consistent results have
been achieved in revealing the genetic component of familial hy-
per- or hypotension. So far, all genes found to cause Mendelian
forms of blood pressure disturbances map to the physiological
pathway regulating water–salt balance in kidneys [12].
Recent studies have reported that single-nucleotide polymor-
phisms within the miRNA target sites can modify miRNA binding,
alter the normal level of target gene expression and contribute to
the pathological phenotype [13,14]. For example, the 30UTR of
angiotensin II receptor I (AGTR1) contains the single-nucleotide
polymorphism (SNP) rs5186 located within the target site for
miR-155. The C allele at this position has been associated with sev-
eral cardiovascular pathologies, including hypertension [15–17].
Two independent studies have shown that this allele drastically
decreases binding of miR-155, thereby resulting in elevated AGTR1
levels and increasing a risk for cardiovascular disease [14,18].
However, reliable target prediction and experimental validation
are still the limiting steps in studying the impact of miRNA-medi-
ated gene regulation on human health.
We set out to study whether regulatory networks responsible
for susceptibility to hypertensionmay include miRNAs. Using in sil-
ico screening of blood pressure candidate genes for possible inter-
actions with miRNAs we identiﬁed mineralocorticoid receptor
728 S. Sõber et al. / Biochemical and Biophysical Research Communications 391 (2010) 727–732NR3C2 (located in 4q31.23), a gene involved in familial hyperten-
sion and renal salt-balance maintenance, as a potential candidate
for miRNA-mediated regulation and veriﬁed experimentally that
it is a target for miR-124 and miR-135a.Table 1
Number of predicted miRNA target sites in blood pressure candidate genes identiﬁed
by Targetscan, PicTar and miRanda.
Gene Targetscan PicTar MiRanda 30UTR length (bp)
ADD1 4 5 34 1891
AGTR2 1 3 58 1195
KCNJ1 1 8 22 1105
NEDD4L 7 28 262 1888
NR3C2 23 64 411 2575
SCNN1A 2 2 131 1026
Averagea 1.97 5.39 74.5 722
a Average target prediction counts and 30UTR lengths are shown for 35 candidate
genes (Supplementary Table S1).Materials and methods
In silico analysis of 160 blood pressure candidate genes. A list of
160 candidate genes reported to be involved in blood pressure reg-
ulation and hypertension was assembled based on literature search
in publicly available databases (Table S1) [9]. This list of 160 genes
was analyzed for miRNA binding sites within 30UTRs using Target-
scan 4.2 [19] data [20]. The signiﬁcance of overrepresentation of
target sites for each miRNA family was estimated using binomial
tests and Bonferroni correction was applied to account for multiple
testing. 30UTRs of a subset of genes (n = 35) involved in regulating
water–salt balance in kidneys and associated with Mendelian hy-
per- and hypotension (Table S1), was screened for miRNA binding
sites using three alternative target prediction algorithms: Target-
scan [20], miRanda [21,22] and picTar [23,24]. Targetscan (con-
served target sites and miRNA families in human, mouse, rat and
dog) and picTar prediction data was downloaded from UCSC gen-
ome browser tracks and miRanda predictions were downloaded
from www.microrna.org [21]. Structure of miRNA-30UTR duplexes
was predicted using RNAhybrid [25,26].
Construction of NR3C2 30UTR reporter. The full-length NR3C2
30UTR was ampliﬁed with primers NR3C2-UTR-F and NR3C2-
UTR-R (Table S3) using Smart-Taq Hot polymerase (Naxo). The
product was digested with BcuI (Fermentas) and FseI (New Eng-
land Biolabs) and ligated into XbaI (Fermentas) and FseI digested
pGL3-Control vector (Promega).
Cloning of miRNA expression plasmids. 450–500 bp genomic re-
gions containing miRNA genes were cloned into pQM-NtagA vector
for expression under the control of a CMV promoter. We ampliﬁed
the genomic sequences containing the following miRNA genes
with the primers given in Table S3: miR-124-1, miR-135a-2, miR-
19b-1, miR-30e, and miR-130a. PCR products were digested with
XbaI and BglII and ligated into the respective sites of the pQM-Nta-
gA (Quattromed) vector to yield miRNA expression plasmids:
pMir124, pMir135a, pMir19b, pMir30e and pMir130a.
Determination of microRNA expression levels. 2.8  105 HeLa cells
were plated on a 6-well cell culture plate in Opti-MEM (Invitrogen)
medium with 10% FCS 24 h prior to transfection. Cells were trans-
fected with 80 ng pRL-TK (Promega), 400 ng pGL3-NR3C2 and
1.6 lg pMir plasmid using Lipofectamine 2000 (Invitrogen) accord-
ing to manufacturer’s instructions. Cells were harvested after 24 h
and total RNA was extracted using mirVANA microRNA isolation
kit (Ambion). miRNA expression was measured by qPCR using Taq-
man microRNA assays (Applied Biosystems) with ABI 7900HT Se-
quence Detection System (Applied Biosystems).
Luciferase assays. 8  104 HeLa cells were plated into 24-well
plates in Opti-MEM (Invitrogen) medium supplemented with 10%
FCS 24 h prior to transfection. Cells were transfected with 20 ng
pRL-TK (Promega), 100 ng pGL3-NR3C2 and 400 ng of appropriate
pMir plasmid using Lipofectamine 2000 (Invitrogen) according to
manufacturer’s instructions. 200 ng + 200 ng of different pMir
plasmids were used for miRNA co-expression assays. Cells were
harvested after 24 h and analysed using Promega dual luciferase
assay. Luciferase activity was measured using TD20/20 lumino-
meter (Turner Designs). Assays were performed in three parallels,
which were replicated three times. Statistical signiﬁcance of re-
sults was calculated using two-tailed Mann–Whitney U test.
Quantitative RT-PCR. For RNA extractions 3  105 cells were pla-
ted into 6-well plates in DMEM + 10% FCS without antibiotics. After
24 h cells were transfected with 80 ng pRL-TK, 400 ng pGL3-NR3C2and 1.6 lg of pMir plasmid using Lipofectamine 2000. After 24 h
incubation cells were harvested and RNA was extracted using
Nucleospin RNA II kit (Macherey–Nagel). Three replicate transfec-
tions were performed.
cDNAs were synthesized from 200 ng of total RNA template
using First Strand cDNA synthesis kit (Fermentas) and oligo dT pri-
mer according to manufacturer’s protocol. Quantitative PCR was
performed in 96-well plates using SYBR Green ROX mix (ABGene)
and ABI 7900HT Sequence Detection System (Applied Biosystems).
The primers used for ampliﬁcations are listed in Table S3. Reac-
tions were performed in 20 ll with 15 min initial denaturation at
95 C. PCR was performed in three replicates. Data was analyzed
using SDS 2.2.2 software (Applied Biosystems). Renilla luciferase
was used as a reference for ﬁreﬂy luciferase reporter mRNA and
endogenous NR3C2 transcript data was normalized against GAPDH.
Results
Bioinformatic assessment of potential miRNA regulation of blood
pressure candidate genes
First, we asked whether target sites for any miRNAs are over-
represented in 30UTRs of genes controlling blood pressure com-
pared to all human genes. We screened 30UTRs of 160 blood
pressure candidate genes (Table S1, [9]) using miRNA binding site
prediction tool Targetscan 4.2 [20]. Binomial tests were performed
for each miRNA family (groups of miRNAs with highly similar se-
quence). We found no evidence for miRNA binding sites that are
speciﬁcally enriched in 30UTRs of blood pressure-regulating genes
(Table S2).
Next, we focused on 35 genes involved in renin–angiotensin–
aldosterone system and other components of renal water–salt bal-
ance regulation (Table S1) and asked whether any of these genes
could be a target for miRNA regulation. miRNA target identiﬁcation
quality was improved by parallel employment of three prediction
programs: Targetscan [20], miRanda [22] and picTar [24]. This
analysis identiﬁed miRNA targets in 13, 27 and 12 genes, respec-
tively. Six genes (ADD1, AGTR2, KCNJ1, NEDD4L, NR3C2, and
SCNN1A) contained target site predictions by all three algorithms
(Table 1). All these genes have unusually long 30UTRs (1026–
2575 bp) (Table 1), a feature that has been associated with miRNA
regulation [27]. Among these, the mineralocorticoid receptor gene,
NR3C2 contained the highest number of predicted miRNA target
sites (23, 64, and 411 for Targetscan, PicTar and miRanda, respec-
tively), indicating that NR3C2 could be under especially intricate
miRNA control.
Selection of miRNAs for experimental validation
In silico prediction was followed by experimental validation of
selected microRNA target sites. We focused on the mineralocorti-
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Fig. 1. Graphic representation of predicted miRNA target sites in NR3C2 30UTR. (A) Venn diagram showing the overlap of miRNA binding sites in NR3C2 30UTR predicted by
alternative algorithms (miRanda, Targetscan, PicTar). Numbers of non-overlapping predictions are indicated for each intersection. (B) Target site predictions from Targetscan,
miRanda and Pictar datasets. Overlapping predictions are indicated with boxes. (C) Targetscan predictions of miRNA target sites selected for validation (depicted as white
boxes). (D) Evolutionary conservation of DNA sequences in 17 vertebrate genomes from UCSC genome browser (http://genome.ucsc.edu/cgi-bin/hgGateway) phastCons track.
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2.5 kb in length and contains a remarkably high number of pre-
dicted miRNA target sites (Table 1 and Fig. 1).
The predicted target sites for miRNAs miR-124, miR-135, miR-
30, miR-19 and miR-130 (Fig. 1C and Fig. S1) were considered to
be best-supported based on the following criteria:
(1) Overlap between target prediction datasets: there was a
considerable difference between the predictions from differ-
ent datasets (Fig. 1A). However, 10 miRNA target sites in the
30UTR of NR3C2 were predicted by all three algorithms
(Fig. 1B and C).
(2) Number of target site predictions in the 30UTR of NR3C2: two
putative target sites for miR-135 and three target sites for
miR-124 were predicted by at least two algorithms.
(3) Quality of binding site predictions: we considered the scor-
ing methods employed by Targetscan due to their solid sta-
tistical approach [28]. A target site for miR-30 was chosen
for validation because it had the highest aggregate PCT score
(indicator of site conservation) for a single site in the Target-
scan dataset.
miRNA variants with the best match to the target sequences
(miR-124, miR-135a, miR-30e, miR-19b, and miR-130a) were se-
lected for validation using a luciferase assay (Fig. S1).
Exogenous and endogenous expression of selected miRNAs in HeLa
cells
Expression plasmids for microRNAs miR-124, miR-135a, miR-
30e, miR-19b, and miR-130a were constructed and tested for capa-bility to produce microRNAs in HeLa cells. The expression of ma-
ture microRNAs was demonstrated by qPCR from all plasmids
(Fig. 2). In HeLa cells, endogenous expression of microRNAs miR-
30e, miR-19b, and miR-130a was detected, while endogenous
miR-124 was undetectable and miR-135a was present in minus-
cule amounts (Fig. 2).
miR-124 and miR-135a down-regulate NR3C2 30UTR luciferase
reporter
In order to validate the predicted miRNA binding sites, co-trans-
fections of NR3C2 30UTR luciferase reporter and expression vectors
for the selected miRNAs (miR-124, miR-135a, miR-30e, miR-19b,
and miR-130a) were performed. Transfections with miR-124 and
miR-135a constructs resulted in signiﬁcant repression of luciferase
activity (P < 0.0001; Fig. 3A). The level of luciferase reporter signal
was repressed 1.5-fold by miR-124 and 2.2-fold by miR-135a com-
pared to transfections with an empty vector. miRNAs miR-30e and
miR-130a repressed the activity of the luciferase reporter to a
smaller extent (1.2-fold) (P < 0.01). miR-19b had no effect on the
reporter activity. These results agree with bioinformatic predic-
tions since the miRNAs with best-supported predictions (miR-
124 and miR-135a) were found to cause the strongest repression.
Co-transfection of multiple miRNAs does not enhance the repression of
NR3C2 reporter
Next, we tested whether simultaneous effect of more than one
miRNA would enhance the silencing of NR3C2. It has been sug-
gested that genes with a regulatory function are often subject to
complex suppression by a number of interacting miRNAs [29].
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Fig. 2. Expression of tested microRNAs in HeLa cells. Expression levels of
endogenous and transfected microRNAs (miR-124, miR-135, miR-30e, miR-19b,
miR-130a) were measured by qPCR (mean of 3–4 replicates) using ABI microRNA
assays. Expression levels are normalized to endogenous miR-135, which was the
miRNA with lowest detectable expression. Error bars represent 99.9% CI. *Expres-
sion was not detectable.
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Fig. 3. Luciferase reporter assays for NR3C2 30UTR reporter construct in HeLa cells.
(A) Reporter construct was cotransfected along with miRNA expression plasmid
(miR-124, miR-135, miR-30e, miR-19b, miR-130a) and luciferase activity was
assayed after 24 h after transfection using dual luciferase reporter assay. The results
of nine replicate experiments are shown. Values were normalised to transfections
with empty pQM-NtagA vector. P values were calculated using two-tailed Mann–
Whitney U test. Error bars represent 95% CI. (B). Effects of miRNA co-expression on
NR3C2 30UTR reporter expression. NR3C2 30UTR luciferase reporter plasmid was
cotransfected with different combinations of expression constructs for miRNAs
strongly repressing NR3C2 reporter (miR-124 and miR-135a) and a miRNA
exhibiting modest repression (miR-130a).
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gest effect (miR-135a and miR-124), and (ii) miRNAwith the stron-
gest effect (miR-135a) and a miRNA with a modest effect on gene
expression (miR-130a). In both experiments, we observed no addi-
tive or synergistic effects between different miRNAs (Fig. 3B). The
co-expression of miR-135a and miR-124a suppressed the lucifer-
ase activity by the same degree (2.2-fold) as miR-135a alone.
Tested miRNAs have no effect on mRNA transcript level
We further asked whether the observed reduction of NR3C2
luciferase reporter protein level results from the repression of
mRNA expression. miRNAs are capable of down-regulating both
mRNA transcription and translation levels of the target gene [1].
Therefore, we measured mRNA levels of both endogenous NR3C2
and the NR3C2 reporter construct using qPCR after transfection
with miRNA expression constructs in HeLa cells. None of the trans-
fected miRNAs were able to decrease the mRNA levels of either
NR3C2 reporter (Fig. 4A) or the endogenous NR3C2 transcript
(Fig. 4B) compared to cells transfected with an empty control vec-
tor. We note that even considering experimental uncertainty the
variation in measured mRNA levels is not sufﬁcient to account
for the observed reduction in luciferase activity (Fig. 3A). Despite
the presence of small amounts of NR3C2 mRNA in HeLa cells, we
were not able to test the effect of miRNA repression on the trans-
lation of endogenous NR3C2 since the level of endogenous protein
in HeLa cell extracts was undetectable by Western blot assay (data
not shown).
Discussion
Based on several recent studies suggesting that miRNAs have a
pivotal role in ﬁne-tuning of regulatory circuits [30], we hypothe-
sized that miRNA-mediated gene-expression modulation may con-
tribute to the functioning of the genes that control blood pressure
levels. To test this hypothesis, we screened hypertension candidate
genes for putative miRNA target sites and experimentally veriﬁed
the mineralocorticoid receptor NR3C2 as a target for miR-124 andmiR-135a. NR3C2 is a ligand-dependent transcription factor that
regulates the expression of ionic and water transporters in re-
sponse to steroid hormones, primarily aldosterone. NR3C2 can af-
fect blood pressure directly by promoting salt retention in the
kidney. In addition, NR3C2 is also expressed in the brain (hypothal-
amus), where it mediates sympathetic regulation of blood volume
homeostasis and inﬂuences salt appetite [31]. The critical role of
NR3C2 in salt balance regulation is shown in NR3C2-deﬁcient mice
that die in early neonatal period from severe sodium and water
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Fig. 4. Quantiﬁcation of the effects of different miRNAs on NR3C2 transcript levels
using qPCR with SYBR green. (A) Quantiﬁcation of NR3C2 30UTR reporter transcript
levels. HeLa cells were cotransfected with NR3C2 reporter and a miRNA expression
plasmid (pMir124, pMir135, pMir30e, pMir19b, pMir130a). RNA was puriﬁed 24 h
after transfection. Error bars represent 95% CI. (B) Quantiﬁcation of endogenous
NR3C2 transcript. Error bars represent 99.9% CI.
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the receptor has been associated with autosomal dominant form of
early-onset hypertension [33]. We found that the expression of
NR3C2 is reduced by miRNAs at the translational but not at the
mRNA level. We suggest that by reducing the amount of mineral-
ocorticoid receptor protein, miR-124 and miR-135a could attenu-
ate signaling in the renin–angiotensin–aldosterone system and
thus participate in regulation of blood pressure.
To investigate the possible role of miRNAs in pathogenesis of
hypertension, the expression proﬁle of miRNAs has been investi-
gated in Dahl salt-sensitive rats [34]. It was shown that miRNA
expression proﬁle in the kidneys and heart of rats on normal and
high-salt diet did not differ, indicating that salt loading does not
have a signiﬁcant effect on miRNA expression. In contrast, a large
number of miRNAs are differentially expressed in cardiac hypertro-
phy [35,36], suggesting their important role in heart failure and
contribution to cardiovascular disorders.
Among 1000 human miRNAs identiﬁed so far, miR-124 is one
of the few with several experimentally veriﬁed targets. Expression
proﬁling of mouse and human organs identiﬁed miR-124a as one
of the brain-speciﬁc miRNAs [37] suggesting its role in neuronal
differentiation. Since mineralocorticoid receptor is functionally
important in the brain [34], miR-124 may have a direct role in reg-ulation of NR3C2 activity in central nervous system. Interestingly,
Vreugdenhil and colleagues [38] have demonstrated that mir-124
can also regulate the glucocorticoid receptor (NR3C1), a paralog
of NR3C2 by binding to a target site near the start of NR3C1 30UTR.
A homologous site is also present in the 30UTR of NR3C2 (Fig. 1C).
miR-135 family is less studied but is known to be expressed in
the kidney and at lower levels in the brain [39].
It has been demonstrated that the number of binding sites with-
in a particular 30UTR can determine the degree of repression [40].
Based on prediction algorithms, NR3C2 contains at least three bind-
ing sites for miR-124 and two sites for miR-135 (Fig. 1). To test
whether coordinate regulation occurs in case of NR3C2, we cotrans-
fected different pairs of miRNAs along with NR3C2 reporter con-
struct. We did not observe neither additive nor synergistic effect
in these experiments. It is possible that we did not observe combi-
natorial effects because of the high level of exogenous miRNAs in
transfected cells that leads to the saturation of the repression path-
way by a single miRNA. We note that the most signiﬁcant repres-
sion in our experiments was generated by microRNAs with
undetectable or low endogenous expression in HeLa cells (miR-
124 and miR-135) (Fig. 2). We cannot exclude the scenario that
the other tested miRNAs (miR-30e, miR-19b, and miR-130a) can
also repress NR3C2 but their effects were masked by the endoge-
nous miRNAs. Variation in the extent of repression by different
miRNAs may also be explained by several other factors, like the ex-
tent of binding site complementarity, sequence context near the
site, location in respect to the stop codon and other miRNA target
sites, as shown by Grimson and colleagues [28].
Conclusions
In summary, bioinformatic screening showed no evidence of
enrichment of speciﬁc miRNA target sites in the 30UTRs of blood
pressure controlling genes. Further inspection of individual genes
identiﬁed NR3C2 as a likely candidate for miRNA regulation. We
showed that miRNAs miR-124 and miR-135a repress NR3C2 trans-
lation in vitro without affecting its mRNA level. In addition we
demonstrated that miR-124 and miR-135a do not act cooperatively
in NR3C2 reporter repression. These data imply that miRNAs can
regulate mineralocorticoid receptor levels and thus may contribute
to the modulation of the functioning of renin–angiotensin–aldoste-
rone system.
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